Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.3 USD | -.--% | -.--% | +6.88% |
24/05 | JOHNSON MATTHEY : Higher transformation costs take their toll | |
23/05 | JOHNSON MATTHEY : ICEs might stay longer |
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.88% | 4.06B | - | ||
+18.74% | 67.26B | A- | ||
-0.95% | 48.54B | A- | ||
+23.65% | 44.21B | B+ | ||
+27.71% | 28.1B | A- | ||
+7.42% | 19.23B | C+ | ||
+11.80% | 16.84B | B+ | ||
-6.51% | 15.86B | B+ | ||
-27.02% | 14.76B | A- | ||
-18.11% | 13.9B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- JMAT Stock
- JMPLF Stock
- Ratings Johnson Matthey Plc